Angiographic features after photodynamic therapy for choroidal neovascularisation in age related macular degeneration and pathological myopia

British Journal of Ophthalmology

Volumn 87, Issue 2, 2003, Pages 177-183

  Parodi, M Baltaglia ^a   Da Pozzo, S ^a   Ravalico, G ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ADULT; ARTICLE; CELL SWELLING; CHOROID VASCULARIZATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; IMAGE ANALYSIS; INDOCYANINE GREEN ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MYOPIA; OPHTHALMOSCOPY; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SAFETY; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME;

CHOROID; CHOROIDAL NEOVASCULARIZATION; COLORING AGENTS; FLUORESCEIN ANGIOGRAPHY; FLUORESCENCE; HUMANS; INDOCYANINE GREEN; MACULAR DEGENERATION; MYOPIA; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; VISUAL ACUITY;

EID: 0037311283     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.87.2.177     Document Type: Article

References (22)

1. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin. One-year results of 2 randomised clinical trials-TAP report 1. Arch Ophthalmol 1999;117:1329-45.
2. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin. Two-year results of 2 randomised clinical trials-TAP report 2. Arch Ophthalmol 2001;119:198-207.
3. Verteporfin in Photodynamic Therapy. Photodynamic therapy of subfoveal choroidal neovascularisation in pathologic myopia with verteporfin. 1-year results of a randomised clinical trial - VIP report 1. Ophthalmology 2001;108:841-52.
4. Verteporfin in Photodynamic Therapy. Verteporfin therapy of subfoveal choroidal neovascularisatlon in age-related macular degeneration: two-year results of a randomised clinical trial including lesions with occult with no classic choroidal neovascularisation - verteporfin in photodynamic therapy report 2. Am J Ophthalmol 2001;131:541-60.
5. Schmidt-Erfurth U, Bauman W, Gragoudas E, et al. Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin. Ophthalmology 1994;101:89-99.
6. Schmidt-Erfurth U, Hasan T, Flotte T, et al. Photodynamic therapy of experimental intraocular tumors with benzoporphyrin-lipoprotein. Ophthalmologe 1994;91:348-56.
7. Schmidt-Erfurth U, Flotte TJ, Gragoudas ES, et al. Benzoporphyrin-lipoprotein-mediated photodestruction of intraocular tumours. Exp Eye Res 1996;62:1-10
8. Schnurrbusch UEK, Welt K, Horn L-C, et al. Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy. Br J Ophthalmol 2001;85:1086-91.
9. Ghazi NG, Jabbour NM, De La Cruz ZC, et al. Clinicopathologic studies of age-related macular degeneration with classic subfoveal choroidal neovascularization treated with photodynamic therapy. Retina 2001;21:478-86.
10. Green WR, McDonnell PJ, Yeo JH. Pathologic features of senile macular degeneration. Ophthalmology 1985;92:615-627.
11. Grossniklaus HE, Hutchinson AK, Capone A Jr, et al. Clinicopathologic features of surgically excised choroidal neovascular membranes. Ophthalmology 1994;101:1099-111.
12. Grossniklaus HE, Green WR. Histopathologic and ultrastructural findings of surgically excised choroidal neovascularization. Submacular Surgery Trials Research Group. Arch Ophthalmol 1998;116:745-9.
13. Grossniklaus HE, Gass JDM. Clinicopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovascular membranes. Am J Ophthalmol 1998;126:59-69.
14. Delori FC, Goger DG, Dorey CK. Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects. Invest Ophthalmol Vis Sci 2001;42:1855-66.
15. Lutty G, Grunwald J, Majji AB, et al. Changes in choriocapillaris and retinal pigment epithelium in age-related macular degeneration. Mol Vis 1999;3:5-35.
16. Green JL, Rabb MF. Degeneration of Bruch's membrane and retinal pigment epithelium. Int Ophthalmol Clin 1981;21:27-50.
17. Green WR, McDonnell PJ, Yeo JH. Pathologic features of senile macular degeneration. Ophthalmology 1985;92:615-27.
18. Okabe S, Nobuhiko M, Okamoto S, et al. Electron microscopic studies on retinochoroidal atrophy in the human eye. Acta Med Okayama 1982;36:11-21.
19. Rabb MF, Garoon I, LaFranco FP. Myopic macular degeneration. Int Ophthalmol Clin 1981;21:51-69.
20. Schmidt-Erfurth U, Miller J, Sickenberg M, et al. Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples. Graefes Arch Clin Exp Ophthalmol 1998;236:365-74.
21. Schmidt-Erfurth U. Indocyanine green angiography and retinal sensitivity after photodynamic therapy of subfoveal choroidal neovascularization. Sem Ophthalmol 1999;14:35-44.
22. Flower RW, Snyder WJ. Expanded hypothesis on the mechanism of photodynamic therapy action on choroidal neovascularization. Retina 1999;5:365-9.